TRAVAMULSION 20% Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Travamulsion 20%, and when can generic versions of Travamulsion 20% launch?
Travamulsion 20% is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in TRAVAMULSION 20% is soybean oil. There are thirteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
Summary for TRAVAMULSION 20%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TRAVAMULSION 20% at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for TRAVAMULSION 20%
US Patents and Regulatory Information for TRAVAMULSION 20%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | TRAVAMULSION 20% | soybean oil | INJECTABLE;INJECTION | 018758-001 | Feb 15, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
